SavedAdd your journal

Journals / Astım Allerji İmmünoloji / 2017 / Cilt: 15 - Sayı: 1

A Case of Acute Generalised Exanthematous Pustulosis Induced by Paracetamol

Parasetamole Bağlı Gelişen Bir Akut Jeneralize Ekzantematöz Püstülozis Olgusu

Şeyhan KUTLUĞ
Mehmet Halil ÇELİKSOY
Betül EROĞLU
Levent YILDIZ
Alişan YILDIRAN
Pages
49–54
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since AGEP is rare in children, we present a ten-month-old boy who developed AGEP after paracetamol use

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute generalized exanthematous pustulosis is an exanthematous disease characterized by a great number of pustules on an acutely erythematous and edematous surface on the skin.
📊
Key Findings & Data:These pustules are smaller than 5 mm, have non-follicular localization, and are sterile and superficial.
💡
Conclusion & Impact:Since AGEP is rare in children, we present a ten-month-old boy who developed AGEP after paracetamol use
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Acute generalized exanthematous pustulosis is an exanthematous disease characterized by a great number of pustules on an acutely erythematous and edematous surface on the skin. These pustules are smaller than 5 mm, have non-follicular localization, and are sterile and superficial. Drugs are held responsible for 90% of the cases and antibiotics are the main culprits. Viral infections, mercury exposure, spider bite and radiation have also been rarely reported as the causative agent. The mortality of AGEP, which is considered to be one of the Severe Cutaneous Adverse Reactions (SCAR), is 5%. Many of the cases reported are adults. Since AGEP is rare in children, we present a ten-month-old boy who developed AGEP after paracetamol use

Özet

Akut jeneralize ekzantematöz püstülozis deri yüzeyinde eritem ve ödemin eşlik ettiği çok sayıda püstül ile karakterize ekzantematöz bir hastalıktır. Bu püstüller 5 mm'den küçük, nonfoliküler yerleşimli, steril ve yüzeyseldir. Hastalığın etiyolojisinde, başta antibiyotikler olmak üzere %90 oranında ilaçlar sorumludur. Viral enfeksiyonlar, civa maruziyeti ve örümcek ısırığı nadiren bildirilmiştir. Akut jeneralize ekzantematöz püstülozis'in mortalitesi %5 oranındadır. Bildirilen olguların büyük çoğunluğu erişkinlerdir. Çocuklarda AGEP nadiren bildirilmiştir. Bu olgu sunumunda, parasetamol sonrası akut jeneralize ekzantematöz püstülozis gelişen on aylık bir erkek hasta bildirilmiştir

🔖

Cite This Article

KUTLUĞ, Ş., ÇELİKSOY, M. H., EROĞLU, B., YILDIZ, L., YILDIRAN, A. (2017). A Case of Acute Generalised Exanthematous Pustulosis Induced by Paracetamol. Astım Allerji İmmünoloji, Cilt: 15 - Sayı: 1, 49–54. https://ajindex.com/articles/146381

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Fitzpatrick’s Dermatology in General Medicine. Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (eds). 6th ed. New York: McGraw-Hill, 2003: 625-627
  2. Sidoroff A, Dunant A, Viboud C, Halevy S, Bavinck JN, Naldi L, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP) - results of a multinational case-control study (EuroSCAR). Br J Dermatol 2007; 157: 989-96
  3. Halevy S. Acute generalized exanthematous pustulosis. Curr Opin Allergy Clin Immunol 2009;9:322-8
  4. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005;209:123-9
  5. Wolkenstein P, Chosidow O, Fléchet ML, Robbiola O, Paul M, Dumé L, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996;35:234-6
  6. Halevy S, Kardaun SH, Davidovici B, Wechsler J; EuroSCAR and RegiSCAR study group. EuroSCAR and RegiSCAR study group. The spectrum of histopathological features in acute generalized exanthematous püstülosis a study of 102 cases. Br J Dermatol 2010;163:1245-52
  7. Beylot C, Bioulac P, Doutre MS. Acute generalized exanthematic pustuloses (four cases). Ann Dermatol Venereol 1980;107:37- 48
  8. Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991;127:1333-8
  9. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP): A clinical reaction pattern. J Cutan Pathol 2001; 28: 113-9
  10. Rezakovic S, Pastar Z, Kostovic K. Cutaneous adverse drug reactions caused by antituberculosis drugs. Inflamm Allergy Drug Targets 2014;13:241-8 11. Schwarz M, Kreuzer KA, Baskaynak G, Dorken B, le Coutre P. Imatinib-induced acute generalized exanthematous pustulosis (AGEP) in two patients with chronic myeloid leukemia. Eur J Haematol 2002;69:254-6
  11. Umayahara T, Shimauchi T, Fujiyama, Ito T, Hirakawa S, Tokura Y. Paediatric acute generalized exanthematous pustulosis induced by paracetamol with high serum levels of Interleukin-8 and -22: A case report. Acta Derm Venereol 2013;93:362-3
  12. Karamfilov T, Wollina U. Juvenile generalized pustular psoriasis. Acta Derm Venereol 1998;78:220
  13. Barbaud A, Collet E, Milpied B, Assier H, Staumont D, AvenelAudran M, et al. Toxidermies group of the French Society of Dermatology. A multicentre study to determine the value and safety of drug patch tests for the th